US FDA peptide decision could create marketing challenges for beauty industry
Yesterday and today, the US FDA Pharmacy Compounding Advisory Committee (PCAC) is discussing adding injectable peptides to the agency’s list of bulk drug substances permitted for use in compounded...
















